Jane Street’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103K Sell
52,600
-3,200
-6% -$7.51K ﹤0.01% 10639
2025
Q4
$151K Buy
+55,800
New +$183K ﹤0.01% 9925
2023
Q4
Sell
-11,600
Closed -$65.3K 9387
2023
Q3
$65.3K Buy
+11,600
New +$77.3K ﹤0.01% 8087
2023
Q2
Sell
-10,800
Closed -$67.5K 8981
2023
Q1
$67.5K Sell
10,800
-5,700
-35% -$31.8K ﹤0.01% 8363
2022
Q4
$76.9K Sell
16,500
-107,800
-87% -$531K ﹤0.01% 8224
2022
Q3
$580K Buy
124,300
+90,900
+272% +$573K ﹤0.01% 6414
2022
Q2
$198K Sell
33,400
-170,100
-84% -$1.89M ﹤0.01% 8198
2022
Q1
$3.93M Buy
203,500
+41,600
+26% +$954K ﹤0.01% 3455
2021
Q4
$5.29M Sell
161,900
-46,500
-22% -$1.87M ﹤0.01% 2769
2021
Q3
$8.55M Buy
208,400
+6,500
+3% +$236K ﹤0.01% 2007
2021
Q2
$7.27M Sell
201,900
-297,000
-60% -$11M ﹤0.01% 2102
2021
Q1
$19.5M Buy
498,900
+70,900
+17% +$3.19M 0.01% 997
2020
Q4
$17.3M Buy
+428,000
New +$19.7M 0.01% 962

Other funds holding GDRX

Jane Street's GDRX Position: Q1 2026 in Review

Jane Street increased its GoodRx Holdings (GDRX) stake by 26% in Q1 2026, buying an estimated $313K and bringing the position to 647,821 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5993.

Jane Street first reported a position in GDRX in Q3 2020 and has held it in 21 quarters since. The position peaked at $18M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Jane Street held 647,821 shares of GoodRx Holdings worth $1.27M as of Q1 2026.
  • Jane Street bought 133,301 GoodRx Holdings shares in Q1 2026, an estimated $313K.
  • GoodRx Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5993 holding.
  • Jane Street first reported a position in GoodRx Holdings in Q3 2020 and has held it in 21 quarters since.
  • Jane Street's GoodRx Holdings position peaked at $18M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.